Predicting Outcomes Following Short-Term Ventricular Assist Device Implant with the MELD-XI Score

Short-term continuous flow (STCF) ventricular assist devices (VADs) are utilized in adults with cardiogenic shock, however, mortality remains high. Previous studies have found that high pre-operative MELD-XI scores in durable VAD patients is associated with mortality. The use of the MELD-XI score to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Artificial organs 2023-11, Vol.47 (11), p.1752-1761
Hauptverfasser: Pidborochynski, Tara, Bozso, Sabin J, Buchholz, Holger, Freed, Darren H, MacArthur, Roderick, Conway, Jennifer
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Short-term continuous flow (STCF) ventricular assist devices (VADs) are utilized in adults with cardiogenic shock, however, mortality remains high. Previous studies have found that high pre-operative MELD-XI scores in durable VAD patients is associated with mortality. The use of the MELD-XI score to predict outcomes in STCF-VAD patients has not been explored. We sought to determine the relationship between MELD-XI and outcomes in adults with STCF-VADs. This was a retrospective review of adults implanted with STCF-VADs between 2009-19. Receiver operating characteristic (ROC) analysis was performed to predict outcomes and Kaplan-Meier analysis was done to assess survival. Seventy-nine patients were included with a median MELD-XI score of 21.2 (IQR 13.5, 27.0). Patients with an unsuccessful wean from support (p
ISSN:0160-564X
1525-1594
DOI:10.1111/aor.14617